Bioventix PLC (LON:BVXP) Insider Purchases £166.53 in Stock

Bioventix PLC (LON:BVXP) insider Bruce Hiscock purchased 61 shares of the business’s stock in a transaction on Monday, December 23rd. The shares were bought at an average cost of GBX 273 ($3.42) per share, with a total value of £166.53 ($208.76).

Bruce Hiscock also recently made the following trade(s):

• On Friday, November 22nd, Bruce Hiscock acquired 24 shares of Bioventix stock. The shares were bought at an average cost of GBX 3,822 ($47.91) per share, for a total transaction of £917.28 ($1,149.91).
• On Wednesday, October 30th, Bruce Hiscock bought 300 shares of Bioventix stock. The stock was purchased at an average cost of GBX 3,330 ($41.75) per share, with a total value of £9,990 ($12,523.51).

Bioventix Price Performance

Shares of LON:BVXP opened at GBX 3,174.76 ($39.80) on Wednesday. The firm’s 50 day simple moving average is GBX 3,634.44 and its two-hundred day simple moving average is GBX 3,989.98. The company has a market capitalization of £165.72 million, a P/E ratio of 1,947.70 and a beta of 0.35. Bioventix PLC has a 1-year low of GBX 2,977 ($37.32) and a 1-year high of GBX 5,100 ($63.93).

Bioventix Increases Dividend

The company also recently announced a dividend, which was paid on Thursday, November 21st. Investors of record on Thursday, November 7th were paid a dividend of GBX 87 ($1.09) per share. This is a boost from Bioventix’s previous dividend of $68.00. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 2.4%. Bioventix’s payout ratio is 9,693.25%.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.